BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 26269223)

  • 1. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
    Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
    Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
    Shah S; Havill J; Rahman MH; Geetha D
    Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
    Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
    Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
    Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
    Front Immunol; 2021; 12():737708. PubMed ID: 34759920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome.
    Naidu GS; Sharma A; Nada R; Kohli HS; Jha V; Gupta KL; Sakhuja V; Rathi M
    Rheumatol Int; 2014 Dec; 34(12):1721-7. PubMed ID: 24838685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
    BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA-mediated crescentic glomerulonephritis with linear deposition of IgG along the glomerular basement membrane.
    Sangsiraprapha W; Truong L; Mandayam S
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):634-7. PubMed ID: 24821165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.
    Minz RW; Chhabra S; Joshi K; Rani L; Sharma N; Sakhuja V; Duggal R; Pasricha N
    Indian J Pathol Microbiol; 2012; 55(1):28-32. PubMed ID: 22499296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pauci-immune necrotizing glomerulonephritis.
    Rutgers A; Sanders JS; Stegeman CA; Kallenberg CG
    Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA-associated pauci-immune glomerulonephritis: always pauci-immune?
    Scaglioni V; Scolnik M; Catoggio LJ; Christiansen SB; Varela CF; Greloni G; Rosa-Diez G; Soriano ER
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):55-58. PubMed ID: 28229825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
    Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
    Front Immunol; 2021; 12():625672. PubMed ID: 33841408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center.
    Li ZY; Gou SJ; Chen M; Zhao MH
    Semin Arthritis Rheum; 2013 Apr; 42(5):515-21. PubMed ID: 23332902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
    Jabur WL; Saeed HM
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
    Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An index for renal outcome in ANCA-associated glomerulonephritis.
    Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
    Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
    Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
    Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
    Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
    Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis].
    Kacprzyk F; Chrzanowski W
    Pol Arch Med Wewn; 1996 Jun; 95(6):514-23. PubMed ID: 9005420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
    Zhao L; David MZ; Hyjek E; Chang A; Meehan SM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.